Vitamin D for COVID-19 Trial (VIVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04536298

Recruitment Status : Active, not recruiting

First Posted : September 2, 2020

Last Update Posted : April 11, 2023

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

Harvard Medical School (HMS and HSDM)

Harvard School of Public Health (HSPH)

Fenway Health and Beth Israel Deaconess Medical Center

Tishcon Corporation

Takeda

Quest Diagnostics-Nichols Insitute

Laboratory Corporation of America

Trialfacts

Karolinska Institutet

Philanthropic donations

Information provided by (Responsible Party):

JoAnn E. Manson, MD, Brigham and Women's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	July 1, 2023
Estimated Study Completion Date :	July 1, 2023

Publications:

Manson JE, Bassuk SS. Commentary. Eliminating vitamin D deficiency during the COVID-19 pandemic: A call to action. Metabolism. 2020 Nov;112:154322. doi: 10.1016/j.metabol.2020.154322. Epub 2020 Jul 23. No abstract available.

Wang R, DeGruttola V, Lei Q, Mayer KH, Redline S, Hazra A, Mora S, Willett WC, Ganmaa D, Manson JE. The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design. Contemp Clin Trials. 2021 Jan;100:106176. doi: 10.1016/j.cct.2020.106176. Epub 2020 Oct 10.

To Top